I'm nearly 49 and was first diagnosed with ITP in summer 2014 following routine blood tests for my rheumatologist, which showed a platelet count below 20. I was referred to a haematologist and prescribed prednisolone and I responded well. Apart from going into withdrawal when I was weaned too quickly from the steroids, I coped and went back to living a normal life.
Nearly a year after diagnosis and just one or two appointments from being discharged, I relapsed and was put back on the steroids. As I reduced my steroid dose, azathioprine was introduced. Unfortunately that damaged my liver and was stopped. After getting off the steroids, my platelet count reduced so was put back on prednisolone for a third time, before I was finally weaned off them again in summer 2017.
As I was being weaned I started losing weight and since June 2017 have lost just over 2.5 stones doing Slimming World, which works for me. I finally got off the steroids again in August 2017 and was on a low dose of mycophenylate but still dealing with the side effects of coming off steroids (achy joints, particularly), when I had a routine appointment October with my haematologist to be told that platelet count had fallen again and I needed to go back on a low dose of steroids with an increased dose of mycophenylate.
I've now had two follow up appointments since being put back on steroids and am not responding very well. My rheumatologist has expressed concern about me being on steroids for all but about 10 months of the last four years, and the side effects for me are horrendous. I have managed to keep losing weight, but it's not easy.
At my recent appointment last week with the haematologist, he discussed putting me on Revolade and gave me a patient leaflet about it. He also introduced me to a key worker. I have read the leaflet several times. I already have cataracts developing and am treated for dry eyes, secondary to limited cutaneous systemic sclerosis (autoimmune). I also have autoimmune hypothyroidism, which having been stable on levothyroxine for the last six or seven years, has recently been shown to be under active so the thyroxine dose has been increased.
Other that what is in the patient leaflet, is there anything else I should know before starting Revolade?
Many thanks and regards